Trium Capital »

Recro Pharma shares owned by Trium Capital

Quarter-by-quarter ownership of Recro Pharma (SCTL) shares owned by Trium Capital from 13F filings

Historical chart of Trium Capital investment in Recro Pharma

Tip: Access up to 7 years of quarterly data

All positions including Recro Pharma held by Trium Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Recro Pharma by Trium Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.1M 1.0M 1.08

More positions owned by Trium Capital

Kraneshares Csi China Intern Csi Chi Internet (KWEB)
Neogames Sa SHS (NGMS)
Pioneer Natural Resources (PXD)
Ishares China Large-cap Etf China Lg-cap Etf (FXI)
Kaman Corporation (KAMN)
Tricon Residential Com Npv (TCN)
Abbott Laboratories (ABT)
Otis Worldwide Corp (OTIS)
Vaneck Vietnam Etf Vaneck Vietnam (VNM)
Daseke (DSKE)
UnitedHealth (UNH)
Moody's Corporation (MCO)
Stryker Corporation (SYK)
Ecolab (ECL)
Cme (CME)

View all positions for Trium Capital

Top funds holding Recro Pharma

First Light Asset Management
Beryl Capital Management
AWM Investment Company
Vanguard Group
OV Management
Geode Capital Management
Trium Capital
Vazirani Asset Management
Skandinaviska Enskilda Banken AB
Crystalline Management
BlackRock
Clear Harbor Asset Management
FNY Investment Advisers
Samjo Management
Bridgeway Capital Management

View all funds holding Recro Pharma